United Therapeutics | UTHR - Operating Profit

Stock Price
567.16
Daily Change
-5.69 -0.99%
Monthly
4.72%
Yearly
94.65%
Q2 Forecast
555.02

United Therapeutics reported $-14.6M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Amarin USD -2.26M 564K Dec/2025
Ardelyx USD 5.1M 431K Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Bayer EUR 1.11B 1.65B Dec/2025
BioCryst Pharmaceuticals USD 260.38M 230.79M Dec/2025
Biogen USD 659.6M 192.2M Sep/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Emergent BioSolutions USD -218M 69.9M Jun/2023
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Halozyme Therapeutics USD -88.41M 306.33M Dec/2025
Insmed USD -249.71M 11.64M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
J&J USD 6.62B 1.03B Mar/2026
Lexicon Pharmaceuticals USD -14.78M 2.59M Dec/2025
Moderna USD -857M 597M Dec/2025
Omeros USD -35.41M 23.75M Sep/2024
Pfizer USD 4.65B 3.99B Dec/2025
PTC Therapeutics USD -81.62M 85.11M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sarepta Therapeutics USD -410.08M 347.2M Dec/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025